Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

Author： Specchia G.   Pastore D.   Carluccio P.   Spinosa G.   Giannoccaro M.   Rizzi R.   Mestice A.   Liso V.  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.86, Iss.6, 2007-06, pp. : 425-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia

By Takeshita Akihiro  

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 703-716

Springer Publishing Company

Access to resources Recommend Favorite

Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution’s experience

By Lee Keun-Wook  

Annals of Hematology, Vol. 83, Iss. 4, 2004-04 ,pp. : 218-224

Springer Publishing Company

Access to resources Recommend Favorite

Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients

By Camera Andrea  

Annals of Hematology, Vol. 88, Iss. 2, 2009-02 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study

By Hołowiecki Jerzy   Grosicki Sebastian   Kyrcz-Krzemien Sławomira   Skotnicki Aleksander   Piatkowska-Jakubas Beata   Warzocha Krzysztof   Seferynska Ilona   Zdziarska Barbara  

Annals of Hematology, Vol. 87, Iss. 5, 2008-05 ,pp. : 361-367

Springer Publishing Company

Access to resources Recommend Favorite

CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis

By Awad Mohamed M.   Aladle Doaa A.   Abousamra Nashwa K.   Elghannam Doaa M.   Fawzy Iman M.  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 61-68

Maney Publishing

Access to resources Recommend Favorite